PP
STJ

Paloma Partners’s St Jude Medical STJ Stock Holding History

Paloma Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-169,475
Closed -$13.5M – 2280
2016
Q3 		$13.5M Buy
169,475
+74,375
+78% +$6M 0.17% 79
2016
Q2 		$7.42M Buy
95,100
+2,119
+2% +$151K 0.08% 154
2016
Q1 		$5.11M Buy
92,981
+72,668
+358% +$3.96M 0.08% 172
2015
Q4 		$1.25M Sell
20,313
-47,737
-70% -$3.01M 0.03% 568
2015
Q3 		$4.29M Buy
68,050
+52,591
+340% +$3.75M 0.1% 135
2015
Q2 		$1.13M Sell
15,459
-26,956
-64% -$1.95M 0.02% 691
2015
Q1 		$2.77M Buy
42,415
+29,470
+228% +$1.96M 0.08% 216
2014
Q4 		$842K Buy
12,945
+6,518
+101% +$420K 0.04% 487
2014
Q3 		$386K Buy
+6,427
New +$420K 0.02% 627
2014
Q2 		– Sell
-18,058
Closed -$1.18M – 1322
2014
Q1 		$1.18M Buy
+18,058
New +$1.18M 0.08% 218

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Paloma Partners's STJ Position: Q4 2016 in Review

Paloma Partners sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 169,475 shares — an estimated $13.5M sold.

Paloma Partners first reported a position in STJ in Q1 2014 and held it in 10 quarters. The position peaked at $13.5M in Q3 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Paloma Partners reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Paloma Partners sold 169,475 St Jude Medical shares in Q4 2016, an estimated $13.5M.
  • Paloma Partners first reported a position in St Jude Medical in Q1 2014 and held it in 10 quarters.
  • Paloma Partners's St Jude Medical position peaked at $13.5M in Q3 2016.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.